1
TÍTULO: Ibrutinib versus temsirolimus in patients with relapsed or refractory mantle-cell lymphoma: an international, randomised, open-label, phase study  Full Text
AUTORES: Martin Dreyling; Wojciech Jurczak; Mats Jerkeman; Rodrigo Santucci Silva; Chiara Rusconi; Marek Trneny; Fritz Offner; Dolores Caballero; Cristina Joao; Mathias Witzens Harig; Georg Hess; Isabelle Bence Bruckler; Seok Goo Cho; John Bothos; Jenna D Goldberg; Christopher Enny; Shana Traina; Sriram Balasubramanian; Nibedita Bandyopadhyay; Steven Sun; Jessica Vermeulen; Aleksandra Rizo; Simon Rule; ...Mais
PUBLICAÇÃO: 2016, FONTE: LANCET, VOLUME: 387, NÚMERO: 10020
INDEXADO EM: Scopus WOS CrossRef
2
TÍTULO: Lymphoma Symptoms: Data from a Phase 3, International, Randomized, Open-Label, Multicenter Study in Patients with Previously Treated Mantle Cell Lymphoma (MCL) Treated with Ibrutinib Vs. Temsirolimus
AUTORES: Georg Hess; Simon Rule; Wojciech Jurczak; Mats Jerkeman; Rodrigo Santucci; Chiara Rusconi; Dolores Caballero; Cristina M Joao; Mathias Witzens Harig; Isabelle Bence Bruckler; Seok Goo Cho; Nibedita Bandyopadhyay; Jenna Goldberg; John Bothos; Christopher Enny; Jessica Vermeulen; Shana Traina; Martin H Dreyling;
PUBLICAÇÃO: 2015, FONTE: 57th Annual Meeting of the American-Society-of-Hematology in BLOOD, VOLUME: 126, NÚMERO: 23
INDEXADO EM: WOS
3
TÍTULO: Ibrutinib Vs Temsirolimus: Results from a Phase 3, International, Randomized, Open-Label, Multicenter Study in Patients with Previously Treated Mantle Cell Lymphoma (MCL)
AUTORES: Simon Rule; Wojciech Jurczak; Mats Jerkeman; Rodrigo Santucci; Chiara Rusconi; Marek Trneny; Fritz Offner; Dolores Caballero; Cristina Joao; Mathias Witzens Harig; Georg Hess; Isabelle Bence Bruckler; Seok Goo Cho; Sriram Balasubramanian; Nibedita Bandyopadhyay; Steven Sun; Jenna Goldberg; John Bothos; Shana Traina; Christopher Enny; Aleksandra Rizo; Jessica Vermeulen; Martin H Dreyling; ...Mais
PUBLICAÇÃO: 2015, FONTE: 57th Annual Meeting of the American-Society-of-Hematology in BLOOD, VOLUME: 126, NÚMERO: 23
INDEXADO EM: WOS
4
TÍTULO: Prespecified Candidate Biomarkers Identify Follicular Lymphoma Patients Who Achieved Longer Progression-Free Survival with Bortezomib-Rituximab Versus Rituximab
AUTORES: Bertrand Coiffier; Weimin M Li; Erin D Henitz; Jayaprakash D Karkera; Reyna Favis; Dana Gaffney; Alice Shapiro; Panteli Theocharous; Yusri A Elsayed; Helgi van de Velde; Michael E Schaffer; Evgenii A Osmanov; Xiaonan N Hong; Adriana Scheliga; Jiri Mayer; Fritz Offner; Simon Rule; Adriana Teixeira; Joanna Romejko Jarosinska; Sven de Vos; Michael Crump; Ofer Shpilberg; Pier Luigi Zinzani; Andrew Cakana; Dixie Lee Esseltine; George Mulligan; Deborah Ricci; ...Mais
PUBLICAÇÃO: 2013, FONTE: CLINICAL CANCER RESEARCH, VOLUME: 19, NÚMERO: 9
INDEXADO EM: Scopus WOS CrossRef